268 related articles for article (PubMed ID: 12921219)
21. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
Jentsch JD; Roth RH; Taylor JR
Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
[TBL] [Abstract][Full Text] [Related]
22. Neurotransmitter interactions related to central dopamine neurons.
Lloyd KG
Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
[No Abstract] [Full Text] [Related]
23. [Dimensional approach to trans-nosographic study of psychotropic drugs].
Jouvent R
Encephale; 1995 Feb; 21 Spec No 1():39-43. PubMed ID: 7729355
[No Abstract] [Full Text] [Related]
24. Psychotropic drugs and dopamine uptake inhibition.
Halaris AE; Freedman DX
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():247-58. PubMed ID: 3829
[No Abstract] [Full Text] [Related]
25. Are You Ready for Change?
Limandri BJ
J Psychosoc Nurs Ment Health Serv; 2018 Feb; 56(2):11-13. PubMed ID: 29385227
[TBL] [Abstract][Full Text] [Related]
26. Psychotropic drug action.
Klein DF
Am J Psychiatry; 1997 Mar; 154(3):440-1. PubMed ID: 9072914
[No Abstract] [Full Text] [Related]
27. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.
Carrey N; Kutcher S
J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031
[No Abstract] [Full Text] [Related]
28. Why drugs and hormones may interact in psychiatric disorders.
Stahl SM
J Clin Psychiatry; 2001 Apr; 62(4):225-6. PubMed ID: 11379834
[No Abstract] [Full Text] [Related]
29. Progress in psychopharmacology.
Post RM; Bunney WE
Curr Psychiatr Ther; 1980; 19():69-87. PubMed ID: 6109596
[No Abstract] [Full Text] [Related]
30. Effect of amphetamine-type psychostimulants on brain metabolism.
Estler CJ
Adv Pharmacol Chemother; 1975; 13():305-57. PubMed ID: 902
[No Abstract] [Full Text] [Related]
31. [Substance regulation of behavior].
de Wied D
Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1284-7. PubMed ID: 6136923
[No Abstract] [Full Text] [Related]
32. Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry.
Kato TA; Yamauchi Y; Horikawa H; Monji A; Mizoguchi Y; Seki Y; Hayakawa K; Utsumi H; Kanba S
Curr Med Chem; 2013; 20(3):331-44. PubMed ID: 23157624
[TBL] [Abstract][Full Text] [Related]
33. Pursuing the actions of psychotropic drugs: receptor sites and endogenous cerebral programmes.
McIlwain H
Psychol Med; 1980 Aug; 10(3):399-402. PubMed ID: 6108586
[No Abstract] [Full Text] [Related]
34. [Effect of mexidol on the level of monoamine mediators and amino acids in rat brain structures].
Miroshnichenko II; Smirnov LD; Voronin AE; Kuz'mina SIu; Veretennikov NA; Burov IuV
Biull Eksp Biol Med; 1996 Feb; 121(2):170-3. PubMed ID: 9026123
[No Abstract] [Full Text] [Related]
35. Nuclear medicine and large animal studies in the pharmacological development of psychotropics.
Peremans K; De Spiegeleer B; Audenaert K
Nucl Med Commun; 2008 Mar; 29(3):191-2. PubMed ID: 18349788
[No Abstract] [Full Text] [Related]
36. The biochemical evaluation of psychotropic drugs.
Mackay AV
Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):42-4. PubMed ID: 973946
[No Abstract] [Full Text] [Related]
37. [Neurotransmitters and behavioral disorders].
Allain H; Schuck S
Encephale; 1998 Jul; 24 Spec No 1():34-7. PubMed ID: 9809253
[No Abstract] [Full Text] [Related]
38. The functional approach of biological research in psychiatry.
López-Ibor JJ
Acta Neurochir Suppl (Wien); 1991; 52():149-53. PubMed ID: 1686520
[TBL] [Abstract][Full Text] [Related]
39. How to appease the appetite of psychotropic drugs.
Stahl SM
J Clin Psychiatry; 1998 Oct; 59(10):500-1. PubMed ID: 9818629
[No Abstract] [Full Text] [Related]
40. [Psychotropic drugs, brain function and sleep. Neurophysiologic aspects of psychopharmacology and pharmacopsychiatry].
Saletu B
Bibl Psychiatr; 1976; (155):1-245. PubMed ID: 802167
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
